Meeting Program
All times are in GMT-3, local time in Brazil.
Thursday, October 26
08:30 - 08:45 Opening ceremony
- A Almeida - President EHA
- JF Comenalli Marques Jr - President ABHH
- C Chiattone - President HEMO 2023
08:45 - 10:15 Session 1: Non-malignant hematology
Chairs: M de los Ángeles Rodríguez (Chile) & A Paats (Paraguay)
- How to personalize the first-line therapy in Follicular Lymphoma
E Kimby (Sweden) - Inherited red cell enzymopathies
L Luzzatto (Italy) - Platelets and inflammation
K Martinod (Belgium)
10:15 - 11:15 Scientific Works with guided works
11:15 - 11:30 Coffee break
11:30 - 13:00 Session 2: State of the Art: Gene therapy, tumor tracking and personalised medicine
Chairs: E Kimby (Sweden) & S Parra Soto (Colombia)
- How to approach relapsed follicular lymphoma
M Ladetto (Italy) - Using ctDNA to track behaviour of aggressive high-risk B-cell lymphomas
S Leppä (Finland) - R Rosenquist (Sweden)
Development of genetic panels across lymphoid malignancies - a path to clinical implementation?
13:00 - 13:30 Lunch break
13:30 - 14:30 Corporate symposia
14:30 - 15:00 Coffee break
15:00 - 16:30 Session 3: Clonal hematopoiesis and myeloid malignancies
Chairs: MA Panozo de los Rios (Bolivia) & L Argumanis (Peru)
- Clonal hematopoiesis – Causes and consequences
K Grønbæk (Denmark) - Mast cells in health and disease
O Hermine (France) - How I diagnosis and prognosticate in CMML
J Ungerstedt (Sweden)
16:30 - 17:00 Coffee break
17:00 - 18:15 Regional Symposium: Drug & Treatment Access
Chairs: D McLornan (United Kingdom) & J Dupont (Argentina)
- Status in Europe
A Almeida (Portugal) - AML
E Rego (Brazil) - Chair
N Aránguiz (Chile)
S Parra Soto (Colombia)
M Zuna (Bolivia)
- Multiple myeloma
A Maiolino (Brazil) - Chair
N Schütz (Argentina)
A Paats (Paraguay)
P Lovato Rios (Peru)
18:15 - 18:30 Closing ceremony
Back